Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

35.89
+0.47161.33%
Post-market: 35.970.0753+0.21%19:30 EDT
Volume:18.95K
Turnover:679.54K
Market Cap:31.41M
PE:- -
High:35.97
Open:35.42
Low:35.42
Close:35.42
52wk High:36.72
52wk Low:24.99
Shares:875.00K
Float Shares:875.00K
Volume Ratio:1.88
T/O Rate:2.17%
Dividend:0.16
Dividend Rate:0.45%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Aug 31

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

Lindian locks in early feed for Kazakh heavy rare earths plant

The West Australian
·
Aug 31

Thermo Fisher Scientific (TMO) Launches New Research Tools As Fair Value Debate Tightens

Simply Wall St.
·
Aug 30

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Aug 30

UnitedHealth Group (UNH), Why Is The Market Paying Closer Attention Now?

Simply Wall St.
·
Aug 30

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

TIPRANKS
·
Aug 29

UnitedHealth, Strategy, Home Depot, Rocket Lab, Applied Shock

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28